98289547 - GLYC OBI

Information

• Trademark
• 98289547

• Source

• Serial Number

  98289547

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 29, 2023
  a year ago

• Transaction Date

  February 14, 2025
  23 days ago

• Status Date

  February 14, 2025
  23 days ago

• Published for Opposition Date

  August 06, 2024
  7 months ago

• Location Date

  February 14, 2025
  23 days ago

• Status Code

  690

• Current Location

  TMEG LAW OFFICE 106

  Employee Name

  OSBORNE, AUDRIANA

• Attorney Docket Number

  10053139

  Attorney Name

  Ran He

  Law Office Assigned Location Code

  L60

• Owners

  • OBI PHARMA INC.

Case File Statements

• DM0000: The mark consists of the black stylized wording "Glyc" and the teal stylized wording "OBI" with a teal curved line below "OBI".
• GS0051: Immunostimulants; Vaccines; Adjuvants for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Chemical reagents for medical or veterinary purposes; Enzyme preparations for medical purposes; Enzymes for medical purposes; Ferments for pharmaceutical purposes; Hormones for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Preparations of microorganisms for medical purposes; Tumor suppressing agents
• PM0001: GLYCOGEN OBI
• CC0000: The color(s) black and teal is/are claimed as a feature of the mark.
• GS0011: Carbide; Cellulose; Glycogen; Glycoprotein; Sulfides; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Adjuvants, other than for medical or veterinary purposes; Antioxidants for use in the manufacture of pharmaceuticals; Biochemical catalysts; Biological preparations for use in industry and science; Carbonic hydrates; Chemical additives for use in the manufacture of pharmaceuticals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Fatty acids for use in pharmaceutical; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Protein in raw material form for scientific and medical research; Proteins for use in manufacture; Proteins for use in the manufacture of drugs
• GS0441: Administering vaccines to patients; Alternative medicine services; Cancer screening services; Cultured cell bank services for medical transplantation; Health care; Health care services for treating cancer; Health assessment services; Health counselling; Human tissue bank services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical assistance; Medical screening; Medical treatment using cultured cells; Nursing, medical; Occupational therapy; Providing health information in the field of cancer prevention and treatment; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Regenerative medicine services; Remote monitoring of medical data for medical diagnosis and treatment; Telemedicine services
• GS0421: Biological research; Biological research and analysis; Chemical analysis; Chemical research; Chemical research and analysis; Chemical research services; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research; Medical research in the field of oncology; Medical research services; Medical research services in the field of cancer; Pharmaceutical research and development; Providing information about medical research in the field of cancer, oncology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research in the field of genetics; Technical research in the field of pharmaceutical studies

Case File Event Statements

• 12/4/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/23/2024 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/24/2024 - a year ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 3/26/2024 - 11 months ago

  5 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 6/27/2024 - 8 months ago

  11 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/26/2024 - 11 months ago

  4 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 3/26/2024 - 11 months ago

  6 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/26/2024 - 8 months ago

  7 - ASSIGNED TO EXAMINER Type: DOCK

• 6/27/2024 - 8 months ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/27/2024 - 8 months ago

  8 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 6/27/2024 - 8 months ago

  10 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 6/27/2024 - 8 months ago

  9 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 7/17/2024 - 7 months ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/6/2024 - 7 months ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/3/2025 - 2 months ago

  17 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD

• 2/13/2025 - 24 days ago

  18 - ASSIGNED TO PETITION STAFF Type: APET

• 2/14/2025 - 23 days ago

  19 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG

• 2/14/2025 - 23 days ago

  20 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT

• 2/14/2025 - 23 days ago

  21 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN

• 2/14/2025 - 23 days ago

  22 - CASE RETURNED TO EXAMINATION Type: OTHE

• 8/6/2024 - 7 months ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/1/2024 - 5 months ago

  16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM